Surgery for metastatic renal cell cancer

World Journal of Urology

Volumn 23, Issue 3, 2005, Pages 155-160

  Sengupta, Shomik ^a   Leibovich, Bradley C ^a   Blute, Michael L ^a   Zincke, Horst ^a  

^a MAYO CLINIC   (United States)

Author keywords

Carcinoma; Metastasis; Neoplasm; Nephrectomy; Renal cell; Surgery

Indexed keywords

HUMAN; KIDNEY CARCINOMA; KIDNEY TUMOR; METASTASIS; NEPHRECTOMY; REVIEW;

CARCINOMA, RENAL CELL; HUMANS; KIDNEY NEOPLASMS; NEPHRECTOMY;

EID: 23744435591     PISSN: 07244983     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00345-005-0504-6     Document Type: Review

References (78)

1. Novick AC, Campbell SC (2002) Renal tumours. In: Walsh PC, Retik AB, Vaughan EDJ, Wein AJ (eds) Campbell's urology. WB Saunders, Philadelphia, pp 2672-2772
2. Wood CG (2003) The role of cytoreductive nephrectomy in the management of metastatic renal cell carcinoma. Urol Clin North Am 30:581-588 10.1016/S0094-0143(03)00026-0
3. Motzer RJ, Bander NH, Nanus DM (1996) Renal-cell carcinoma. N Engl J Med 335:865-875 10.1056/NEJM199609193351207
4. Neves RJ, Zincke H, Taylor WF (1988) Metastatic renal cell cancer and radical nephrectomy: Identification of prognostic factors and patient survival. J Urol 139:1173-1176 1:STN:280:BieB3s%2Fmt1A%3D
5. Kirkali Z, Tuzel E, Mungan MU (2001) Recent advances in kidney cancer and metastatic disease. BJU Int 88:818-824 10.1046/ j.1464-4096.2001.02442.x
6. Fishman M, Seigne J (2002) Immunotherapy of metastatic renal cell cancer. Cancer Control 9:293-304 12228755
7. Flanigan RC (1996) Role of surgery in patients with metastatic renal cell carcinoma. Semin Urol Oncol 14:227-229 1:STN:280:ByiC3c3htVw%3D
8. Yonover PM, Sharma SK, Flanigan RC (2003) Role of nephrectomy in metastatic kidney cancer. Cancer Treat Res 116:119-135 14650829
9. Munro NP, Woodhams S, Nawrocki JD, Fletcher MS, Thomas PJ (2003) The role of transarterial embolization in the treatment of renal cell carcinoma. BJU Int 92:240-244 10.1046/j.1464-410X.2003.04314.x
10. Volkmer BG, Gschwend JE (2002) Value of metastases surgery in metastatic renal cell carcinoma, in German. Urologe A 41:225-230 10.1007/ s00120-002-0204-4
11. Olerud C, Jonsson B (1996) Surgical palliation of symptomatic spinal metastases. Acta Orthop Scand 67:513-522 1:STN:280:ByiC3cvgvFI%3D
12. Wedin R (2001) Surgical treatment for pathologic fracture. Acta Orthop Scand [Suppl] 72: 1-29
13. Stepanek E, Josph S, Campbell P, Porte M (1999) Embolization of a limb metastasis in renal cell carcinoma as a palliative treatment of bone pain. Clin Radiol 54:855-857 10.1016/S0009-9260(99)90695-5
14. Swanson DA, Johnson DE, Von Eschenbach AC, Chuang VP, Wallace S (1983) Angioinfarction plus nephrectomy for metastatic renal cell carcinoma - an update. J Urol 130:449-452
15. Kurth KH, Debruyne FM, Hall RR, Denis L, Verbaes A, Bollack C, De Voogt HJ, De Pauw M, Silvester R (1987) Embolization and postinfarction nephrectomy in patients with primary metastatic renal adenocarcinoma. Eur Urol 13:251-255 1:STN:280:BieD3cvlvVU%3D
16. Mebust WK, Weigel JW, Lee KR, Cox GG, Jewell WR, Krishnan EC (1984) Renal cell carcinoma - angioinfarction. J Urol 131:231-235 1:STN:280:BiuC3sfptFQ%3D
17. Gottesman JE, Crawford ED, Grossman HB, Scardino P, McCracken JD (1985) Infarction-nephrectomy for metastatic renal carcinoma. Southwest oncology group study. Urology 25:248-250 10.1016/0090-4295(85)90321-8
18. Minasian LM, Motzer RJ, Gluck L, Mazumdar M, Vlamis V, Krown SE (1993) Interferon alfa-2a in advanced renal cell carcinoma: Treatment results and survival in 159 patients with long-term follow-up. J Clin Oncol 11:1368-1375. 1:STN:280:ByyA3c7mslA%3D
19. Joffe JK, Banks RE, Forbes MA, Hallam S, Jenkins A, Patel PM, Hall GD, Velikova G, Adams J, Crossley A et al. (1996) A phase II study of interferon-alpha, interleukin-2 and 5-fluorouracil in advanced renal carcinoma: Clinical data and laboratory evidence of protease activation. Br J Urol 77:638-649 1:CAS:528:DyaK28XjsFWqtb8%3D
20. Quesada JR, Rios A, Swanson D, Trown P, Gutterman JU (1985) Antitumor activity of recombinant-derived interferon alpha in metastatic renal cell carcinoma. J Clin Oncol 3:1522-1528 1:STN:280:BimD3snjs1Y%3D
21. Ljungberg B, Landberg G, Alamdari FI (2000) Factors of importance for prediction of survival in patients with metastatic renal cell carcinoma, treated with or without nephrectomy. Scand J Urol Nephrol 34:246-251 10.1080/003655900750041979
22. Mosharafa A, Koch M, Shalhav A, Gardner T, Logan T, Bihrle R, Foster R (2003) Nephrectomy for metastatic renal cell carcinoma: Indiana University experience. Urology 62:636-640 10.1016/S0090-4295(03)00682-4
23. Fujikawa K, Matsui Y, Miura K, Kobayashi T, Oka H, Fukuzawa S, Takeuchi H (2000) Serum immunosuppressive acidic protein and natural killer cell activity in patients with metastatic renal cell carcinoma before and after nephrectomy. J Urol 164:673-675 10.1097/00005392-200009010-00013
24. Dadian G, Riches PG, Henderson DC, Taylor A, Moore J, Atkinson H, Gore ME (1994) Immunological parameters in peripheral blood of patients with renal cell carcinoma before and after nephrectomy. Br J Urol 74:15-22 1:STN:280:ByuA3MbnsVU%3D
25. Montie JE, Straffon RA, Deodhar SD, Barna B (1976) In vitro assessment of cell-mediated immunity in patients with renal cell carcinoma. J Urol 115:239-242 1:STN:280:CSmC2cnpvFY%3D
26. Flanigan RC, Salmon SE, Blumenstein BA, Bearman SI, Roy V, McGrath PC, Caton JRJr, Munshi N, Crawford ED (2001) Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b alone for metastatic renal-cell cancer. N Engl J Med 345:1655-1659 10.1056/NEJMoa003013
27. Jocham D, Richter A, Hoffmann L, Iwig K, Fahlenkamp D, Zakrzewski G, Schmitt E, Dannenberg T, Lehmacher W, Von Wietersheim J et al. (2004) Adjuvant autologous renal tumour cell vaccine and risk of tumour progression in patients with renal-cell carcinoma after radical nephrectomy: Phase III, randomised controlled trial. Lancet 363:594-599 10.1016/S0140-6736(04)15590-6
28. Figlin RA, Thompson JA, Bukowski RM, Vogelzang NJ, Novick AC, Lange P, Steinberg GD, Belldegrun AS (1999) Multicenter, randomized, phase III trial of CD8(+) tumor-infiltrating lymphocytes in combination with recombinant interleukin-2 in metastatic renal cell carcinoma. J Clin Oncol 17:2521-2529 1:STN:280:DC%2BD3c%2FjtVSntQ%3D%3D
29. Rackley R, Novick A, Klein E, Bukowski R, McLain D, Goldfarb D (1994) The impact of adjuvant nephrectomy on multimodality treatment of metastatic renal cell carcinoma. J Urol 152:1399-1403 1:STN:280:ByqD3MfntVY%3D
30. Bennett RT, Lerner SE, Taub HC, Dutcher JP, Fleischmann J (1995) Cytoreductive surgery for stage IV renal cell carcinoma. J Urol 154:32-34 10.1097/00005392-199507000-00013
31. Mani S, Todd MB, Katz K, Poo WJ (1995) Prognostic factors for survival in patients with metastatic renal cancer treated with biological response modifiers. J Urol 154:35-40 10.1097/00005392-199507000-00014
32. Figlin RA, Pierce WC, Kaboo R, Tso CL, Moldawer N, Gitlitz B, DeKernion J, Belldegrun A (1997) Treatment of metastatic renal cell carcinoma with nephrectomy, interleukin-2 and cytokine-primed or CD8(+) selected tumor infiltrating lymphocytes from primary tumor. J Urol 158:740-745 10.1097/ 00005392-199709000-00012
33. Fallick ML, McDermott DF, LaRock D, Long JP, Atkins MB (1997) Nephrectomy before interleukin-2 therapy for patients with metastatic renal cell carcinoma. J Urol 158:1691-1695 1:CAS:528:DyaK1cXmsVOrt7c%3D
34. Wagner JR, Walther MM, Linehan WM, White DE, Rosenberg SA, Yang JC (1999) Interleukin-2 based immunotherapy for metastatic renal cell carcinoma with the kidney in place. J Urol 162:43-45 10.1097/ 00005392-199907000-00011
35. Walther MM, Yang JC, Pass HI, Linehan WM, Rosenberg SA (1997) Cytoreductive surgery before high dose interleukin-2 based therapy in patients with metastatic renal cell carcinoma. J Urol 158:1675-1678 1:CAS:528:DyaK1cXmsVOrt7k%3D
36. Levy DA, Swanson DA, Slaton JW, Ellerhorst J, Dinney CP (1998) Timely delivery of biological therapy after cytoreductive nephrectomy in carefully selected patients with metastatic renal cell carcinoma. J Urol 159:1168-1173 10.1097/00005392-199804000-00015
37. Tigrani VS, Reese DM, Small EJ, Presti JCJr, Carroll PR (2000) Potential role of nephrectomy in the treatment of metastatic renal cell carcinoma: a retrospective analysis. Urology 55:36-40 10.1016/S0090-4295(99)00395-7
38. Pantuck AJ, Belldegrun AS, Figlin RA (2001) Nephrectomy and interleukin-2 for metastatic renal-cell carcinoma. N Engl J Med 345:1711-1712 10.1056/NEJM200112063452317
39. Mickisch GH, Garin A, Van Poppel H, De Prijck L, Sylvester R (2001) Radical nephrectomy plus interferon-alfa-based immunotherapy compared with interferon alfa alone in metastatic renal-cell carcinoma: A randomised trial. Lancet 358:966-970 10.1016/S0140-6736(01)06103-7
40. Flanigan RC, Mickisch G, Sylvester R, Tangen C, Van Poppel H, Crawford ED (2004) Cytoreductive nephrectomy in patients with metastatic renal cancer: A combined analysis. J Urol 171:1071-1076 10.1097/ 01.ju.0000110610.61545.ae
41. Eggermont AM, Steller EP, Sugarbaker PH (1987) Laparotomy enhances intraperitoneal tumor growth and abrogates the antitumor effects of interleukin-2 and lymphokine-activated killer cells. Surgery 102:71-78 1:STN:280:BiiB3svptVI%3D
42. Sella A, Swanson DA, Ro JY, Putnam JBJr, Amato RJ, Markowitz AB, Logothetis CJ (1993) Surgery following response to interferon-alpha-based therapy for residual renal cell carcinoma. J Urol 149:19-22 1:STN:280:ByyC3cfltlI%3D
43. Bex A, Horenblas S, Meinhardt W, Verra N, De Gast GC (2002) The role of initial immunotherapy as selection for nephrectomy in patients with metastatic renal cell carcinoma and the primary tumor in situ. Eur Urol 42:570-576 10.1016/S0302-2838(02)00404-9
44. Kim B, Louie AC (1992) Surgical resection following interleukin 2 therapy for metastatic renal cell carcinoma prolongs remission. Arch Surg 127:1343-1349 1:STN:280:ByyD2svjvVI%3D
45. Krishnamurthi V, Novick AC, Bukowski RM (1998) Efficacy of multimodality therapy in advanced renal cell carcinoma. Urology 51:933-937 10.1016/ S0090-4295(98)00033-8
46. Zisman A, Pantuck AJ, Chao DH, Wieder JA, Dorey F, Said JW, Kernion JB, Figlin R, Belldegrun AS (2002) Renal cell carcinoma with tumor thrombus: is cytoreductive nephrectomy for advanced disease associated with an increased complication rate? J Urol 168:962-967 10.1097/ 00005392-200209000-00015
47. Slaton JW, Balbay MD, Levy DA, Pisters LL, Nesbitt JC, Swanson DA, Dinney CP (1997) Nephrectomy and vena caval thrombectomy in patients with metastatic renal cell carcinoma. Urology 50:673-677 10.1016/ S0090-4295(97)00329-4
48. Walther MM, Lyne JC, Libutti SK, Linehan WM (1999) Laparoscopic cytoreductive nephrectomy as preparation for administration of systemic interleukin-2 in the treatment of metastatic renal cell carcinoma: A pilot study. Urology 53:496-501 10.1016/S0090-4295(98)00562-7
49. Bromwich E, Hendry D, Aitchison M (2002) Cytoreductive nephrectomy: Is it a realistic option in patients with renal cancer? BJU Int 89:523-525 10.1046/j.1464-410X.2002.02631.x
50. Mejean A, Roupret M, Larousserie F, Hopirtean V, Thiounn N, Dufour B (2003) Is there a place for radical nephrectomy in the presence of metastatic collecting duct (Bellini) carcinoma? J Urol 169:1287-1290 10.1097/01.ju.0000050221.51509.f5
51. Calvo FA, Zincke H, Gunderson LL, Aristu J, Gerard JP, Berian JM (1999) Genitourinary IORT. In: Gunderson LL, Willett CG, Harrison LB, Calvo FA (eds) Intraoperative irradiation: Techniques and results. Humana, Totowa, pp 421-436
52. Frydenberg M, Gunderson L, Hahn G, Fieck J, Zincke H (1994) Preoperative external beam radiotherapy followed by cytoreductive surgery and intraoperative radiotherapy for locally advanced primary or recurrent renal malignancies. J Urol 152:15-21 1:STN:280:ByuB28%2Flslw%3D
53. Santos M, Ucar A, Ramos H, Escude L, Berian JM, Zudaire J, Calvo FA (1989) Intraoperative radiotherapy in locally advanced carcinoma of the kidney: Initial experience, in Spanish. Actas Urol Esp 13:36-40 1:STN:280:BiaB38rktVA%3D
54. Eble MJ, Stahler G, Wannenmacher M (1997) IORT for locally advanced or recurrent renal cell carcinoma. Front Radiat Ther Oncol 31:253-255 1:STN:280:ByiH3cbkslA%3D
55. De Riese W, Goldenberg K, Allhoff E, Stief C, Schlick R, Liedke S, Jonas U (1991) Metastatic renal cell carcinoma (RCC): Spontaneous regression, long-term survival and late recurrence. Int Urol Nephrol 23:13-25 1938215
56. Aref I, Bociek RG, Salhani D (1997) Is post-operative radiation for renal cell carcinoma justified? Radiother Oncol 43:155-157 10.1016/ S0167-8140(97)01949-X
57. Buskirk SJ, Smalley SR, Zincke H (2000) Kidney and Ureteral Carcinoma. In: Gunderson L, Tepper JE (eds) Clinical radiation oncology. Churchill Livingstone, New York, pp 863-878
58. Kavolius JP, Mastorakos DP, Pavlovich C, Russo P, Burt ME, Brady MS (1998) Resection of metastatic renal cell carcinoma. J Clin Oncol 16:2261-2266 1:STN:280:DyaK1c3ovFCluw%3D%3D
59. Kierney PC, Van Heerden JA, Segura JW, Weaver AL (1994) Surgeon's role in the management of solitary renal cell carcinoma metastases occurring subsequent to initial curative nephrectomy: An institutional review. Ann Surg Oncol 1:345-352
60. O'Dea M J, Zincke H, Utz DC, Bernatz PE (1978) The treatment of renal cell carcinoma with solitary metastasis. J Urol 120:540-542 712892
61. Piltz S, Meimarakis G, Wichmann MW, Hatz R, Schildberg FW, Fuerst H (2002) Long-term results after pulmonary resection of renal cell carcinoma metastases. Ann Thorac Surg 73:1082-1087
62. Pfannschmidt J, Hoffmann H, Muley T, Krysa S, Trainer C, Dienemann H (2002) Prognostic factors for survival after pulmonary resection of metastatic renal cell carcinoma. Ann Thorac Surg 74:1653-1657
63. Alves A, Adam R, Majno P, Delvart V, Azoulay D, Castaing D, Bismuth H (2003) Hepatic resection for metastatic renal tumors: Is it worthwhile? Ann Surg Oncol 10:705-710
64. Lau WK, Zincke H, Lohse CM, Cheville JC, Weaver AL, Blute ML (2003) Contralateral adrenal metastasis of renal cell carcinoma: Treatment, outcome and a review. BJU Int 91:775-779 10.1046/j.1464-410X.2003.04237.x
65. Harada Y, Nonomura N, Kondo M, Nishimura K, Takahara S, Miki T, Okuyama A (1999) Clinical study of brain metastasis of renal cell carcinoma. Eur Urol 36:230-235 10.1159/000068003
66. Badalament RA, Gluck RW, Wong GY, Gnecco C, Kreutzer E, Herr HW, Fair WR, Galicich JH (1990) Surgical treatment of brain metastases from renal cell carcinoma. Urology 36:112117 10.1016/0090-4295(90)80208-5
67. Ghavamian R, Klein KA, Stephens DH, Welch TJ, LeRoy AJ, Richardson RL, Burch PA, Zincke H (2000) Renal cell carcinoma metastatic to the pancreas: Clinical and radiological features. Mayo Clin Proc 75:581-585 1:STN:280:DC%2BD3czgvFamug%3D%3D
68. Sohn TA, Yeo CJ, Cameron JL, Nakeeb A, Lillemoe KD (2001) Renal cell carcinoma metastatic to the pancreas: Results of surgical management. J Gastrointest Surg 5:346-351 10.1016/S1091-255X(01)80060-3
69. Law CH, Wei AC, Hanna SS, Al-Zahrani M, Taylor BR, Greig PD, Langer B, Gallinger S (2003) Pancreatic resection for metastatic renal cell carcinoma: Presentation, treatment, and outcome. Ann Surg Oncol 10:922-926
70. Itano NB, Blute ML, Spotts B, Zincke H (2000) Outcome of isolated renal cell carcinoma fossa recurrence after nephrectomy. J Urol 164:322-325 10.1097/00005392-200008000-00011
71. Schrodter S, Hakenberg OW, Manseck A, Leike S, Wirth MP (2002) Outcome of surgical treatment of isolated local recurrence after radical nephrectomy for renal cell carcinoma. J Urol 167:1630-1633 10.1097/ 00005392-200204000-00013
72. Wiesner C, Jakse G, Rohde D (2002) Therapy of local recurrence of renal cell carcinoma. Oncol Rep 9:189-192 11748481
73. Blom JH, Van Poppel H, Marechal JM, Jacqmin D, Sylvester R, Schroder FH, De Prijck L (1999) Radical nephrectomy with and without lymph node dissection: Preliminary results of the EORTC randomized phase III protocol 30881. EORTC Genitourinary Group. Eur Urol 36:570-575 10.1159/ 000020050
74. Blute ML, Leibovich BC, Cheville JC, Lohse CM, Zincke H (2004) A protocol for performing extended lymph node dissection using primary tumor pathological features for patients treated with radical nephrectomy for clear cell renal cell carcinoma. J Urol 172:465-469 10.1097/01.ju.0000129815.91927.85
75. Pantuck AJ, Zisman A, Dorey F, Chao DH, Han KR, Said J, Gitlitz BJ, Figlin RA, Belldegrun AS (2003) Renal cell carcinoma with retroperitoneal lymph nodes: Role of lymph node dissection. J Urol 169:2076-2083 12771723
76. Tatsuta M, Shiozaki K, Masutani S, Hashimoto K, Imamura H, Ikeda M, Miya A, Ishida H, Kawasaki T, Furukawa H et al. (2001) Splenic and pulmonary metastases from renal cell carcinoma: Report of a case. Surg Today 31:463-465 10.1007/s005950170142
77. Lokich J (1997) Spontaneous regression of metastatic renal cancer. Case report and literature review. Am J Clin Oncol 20:416-418 10.1097/ 00000421-199708000-00020
78. Blom JH, Van Poppel H, Marechal JM, Jacqmin D, Sylvester R, Schroder FH, De Prijck L (1999) Radical nephrectomy with and without lymph node dissection: Preliminary results of the EORTC randomized phase III protocol 30881. EORTC Genitourinary Group. Eur Urol 36:570-575 10.1159/000020050